| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Horst J. Schirra | Q46799595 |
| Baogang Xie | Q57318695 | ||
| P2093 | author name string | Michael J. Waters | |
| P2860 | cites work | Metabolomic Analysis of Livers and Serum from High-Fat Diet Induced Obese Mice | Q82292576 |
| Leucine in food mediates some of the postprandial rise in plasma leptin concentrations | Q83201758 | ||
| Differentiating short- and long-term effects of diet in the obese mouse using (1) H-nuclear magnetic resonance metabolomics | Q83841032 | ||
| The Kennedy pathway-De novo synthesis of phosphatidylethanolamine and phosphatidylcholine | Q103359360 | ||
| Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease | Q24601951 | ||
| An obesity-associated gut microbiome with increased capacity for energy harvest | Q27860515 | ||
| Alterations in hepatic one-carbon metabolism and related pathways following a high-fat dietary intervention | Q27887317 | ||
| A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance | Q28240815 | ||
| Phylometabonomic patterns of adaptation to high fat diet feeding in inbred mice | Q28472224 | ||
| Altered metabolism of growth hormone receptor mutant mice: a combined NMR metabonomics and microarray study | Q28504973 | ||
| Metabolite profiles and the risk of developing diabetes | Q29615359 | ||
| The BCAA-BCKA cycle: its relation to alanine and glutamine synthesis and protein balance | Q31881098 | ||
| Metabolic phenotyping of genetically modified mice: An NMR metabonomic approach. | Q33442356 | ||
| Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years. | Q33545914 | ||
| In vivo analysis of growth hormone receptor signaling domains and their associated transcripts | Q33551712 | ||
| Metabolic profiling of plasma in overweight/obese and lean men using ultra performance liquid chromatography and Q-TOF mass spectrometry (UPLC-Q-TOF MS). | Q33609006 | ||
| Integration of metabolomics and transcriptomics data to aid biomarker discovery in type 2 diabetes | Q33612373 | ||
| Taurine improves insulin sensitivity in the Otsuka Long-Evans Tokushima Fatty rat, a model of spontaneous type 2 diabetes | Q33885338 | ||
| Choline: an essential nutrient for humans | Q33976000 | ||
| Exercise promotes BCAA catabolism: effects of BCAA supplementation on skeletal muscle during exercise | Q33978832 | ||
| The relation between plasma concentrations of glutamine and glycine and utilization of their nitrogens as sources of urinary ammonia | Q34080194 | ||
| Lactate release from the subcutaneous tissue in lean and obese men. | Q34119903 | ||
| Glutamine and glutamate as vital metabolites | Q34174552 | ||
| A metabonomic comparison of urinary changes in Zucker and GK rats | Q34239102 | ||
| Beneficial effects of taurine on serum lipids in overweight or obese non-diabetic subjects | Q34329611 | ||
| Chemical inhibition of citrate metabolism alters body fat content in mice | Q46980144 | ||
| Systems biology: Metabonomics | Q47647280 | ||
| Long-term oral branched chain amino acids in patients undergoing chemoembolization for hepatocellular carcinoma: a randomized trial | Q47885824 | ||
| Choline, a vital amine. | Q48406677 | ||
| Increased prevalence of high Body Mass Index in patients presenting with pituitary tumours: severe obesity in patients with macroprolactinoma | Q48534290 | ||
| Applications of metabolomics to understanding obesity in mouse and man. | Q48541538 | ||
| Hypoglycemic effect of isoleucine involves increased muscle glucose uptake and whole body glucose oxidation and decreased hepatic gluconeogenesis. | Q51478315 | ||
| Insulin resistance and low urinary citrate excretion in calcium stone formers. | Q51482858 | ||
| Metabolomic response to exercise training in lean and diet-induced obese mice. | Q51609397 | ||
| Effect of obesity on ambient plasma glucose, free fatty acid, insulin, growth hormone, and glucagon concentrations. | Q51633156 | ||
| Plasma Amino Acid Levels and Insulin Secretion in Obesity | Q51685623 | ||
| Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis. | Q53555710 | ||
| Creatinine clearance in renal disease. A reappraisal | Q55436059 | ||
| Carnitine: a nutritional, biosynthetic, and functional perspective | Q34347813 | ||
| Splanchnic glucose and amino acid metabolism in obesity | Q34462199 | ||
| Taurine (2-aminoethanesulfonic acid) deficiency creates a vicious circle promoting obesity | Q34515680 | ||
| Childhood obesity: future directions and research priorities | Q34841024 | ||
| Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice | Q35033766 | ||
| Metabolic acidosis-induced insulin resistance and cardiovascular risk | Q35163137 | ||
| Microarray gene expression profiling in obesity and insulin resistance | Q35617567 | ||
| OMICS-driven biomarker discovery in nutrition and health | Q36442739 | ||
| Metabonomics techniques and applications to pharmaceutical research & development | Q36484646 | ||
| Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet | Q36558384 | ||
| Lowered concentrations of branched-chain amino acids result in impaired growth and neurological problems: insights from a branched-chain alpha-keto acid dehydrogenase complex kinase-deficient mouse model | Q36822294 | ||
| Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality | Q36971461 | ||
| Effect of starvation on the turnover and metabolic response to leucine | Q37054098 | ||
| Effects of L-carnitine on obesity, diabetes, and as an ergogenic aid. | Q37093371 | ||
| Clinical applications of metabolomics in oncology: a review | Q37177549 | ||
| The contribution of animal models to the study of obesity | Q37265313 | ||
| Obesity-related elevations in plasma leucine are associated with alterations in enzymes involved in branched-chain amino acid metabolism. | Q37399240 | ||
| Integrated omics approaches in plant systems biology | Q37616889 | ||
| Spectroscopic and statistical techniques for information recovery in metabonomics and metabolomics | Q37773335 | ||
| ¹H NMR-based metabonomics for investigating diabetes | Q37855850 | ||
| Obesity in China: what are the causes? | Q37865037 | ||
| The impact of choline availability on muscle lipid metabolism | Q39504000 | ||
| Glucose-Lactate Inter-Relations in Man | Q39915500 | ||
| Citrate excretion: a window on renal metabolism | Q40145862 | ||
| Urinary excretion of choline metabolites following choline administration in normals and patients with hepatobiliary diseases | Q40980285 | ||
| Amino acid pattern in plasma before and after jejuno-ileal shunt operation for obesity | Q42150755 | ||
| Effect of enteral glutamine or glycine on whole-body nitrogen kinetics in very-low-birth-weight infants | Q42457684 | ||
| Gut microbiome-derived metabolites characterize a peculiar obese urinary metabotype. | Q43138002 | ||
| 1H-nuclear magnetic resonance spectroscopy-based metabolic assessment in a rat model of obesity induced by a high-fat diet. | Q43285146 | ||
| Serum fatty acid composition predicts development of impaired fasting glycaemia and diabetes in middle-aged men. | Q44024459 | ||
| Preventing cardiovascular disease in hypertension: effects of lowering blood pressure and cholesterol | Q44231259 | ||
| The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance | Q44691209 | ||
| Altered plasma free amino acid levels in obese traumatized man. | Q45332653 | ||
| Combined proteomic and metabolomic profiling of serum reveals association of the complement system with obesity and identifies novel markers of body fat mass changes | Q45739398 | ||
| Metabolomics study with gas chromatography-mass spectrometry for predicting valproic acid-induced hepatotoxicity and discovery of novel biomarkers in rat urine. | Q45928289 | ||
| Top-down systems biology modeling of host metabotype-microbiome associations in obese rodents | Q46093540 | ||
| Transcriptomic and metabonomic profiling of obesity-prone and obesity-resistant rats under high fat diet. | Q46337315 | ||
| Metabolic profiling of livers and blood from obese Zucker rats | Q46751580 | ||
| Metabolomic profiling of dietary-induced insulin resistance in the high fat-fed C57BL/6J mouse. | Q46794705 | ||
| Plasma fatty acid composition and incidence of diabetes in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study | Q57306780 | ||
| The serum cholesterol ester fatty acid composition but not the serum concentration of alpha tocopherol predicts the development of myocardial infarction in 50-year-old men: 19 years follow-up | Q61442776 | ||
| The exogenous origin of trimethylamine in the mouse | Q67745082 | ||
| Effect of diet on creatinine clearance and excretion in young and elderly healthy subjects and in patients with renal disease | Q67781323 | ||
| [Evaluation of renal function in chronic renal disease with special reference to creatinine] | Q68652854 | ||
| Fatty acid composition in serum lipids and adipose tissue in severe obesity before and after six weeks of weight loss | Q69385438 | ||
| Citrate metabolism in diabetes. I. Plasma citrate in alloxan-diabetic rats and in clinical diabetes | Q69985768 | ||
| Insulin-dependent metabolism of branched-chain amino acids in obesity | Q70316122 | ||
| Hormone and amino acid levels in altered nutritional states | Q71585805 | ||
| Cardioprotective actions of taurine against intracellular and extracellular calcium-induced effects | Q72623411 | ||
| Glomerular hemodynamics in severe obesity | Q73782711 | ||
| THE RELATIONSHIP OF URINARY 17-HYDROXYCORTICOSTEROIDS TO CREATININE IN OBESITY | Q77072613 | ||
| [Prevalence of obesity in developed countries: current status and perspectives] | Q77862830 | ||
| Effect of Insulin and Tolbutamide on Blood Citric Acid in Rabbits | Q78861232 | ||
| Metabolic control of creatine biosynthesis. II. Restoration of transamidinase activity following creatine repression | Q79100288 | ||
| Dynamic control of calcium, phosphate, citrate, and glucose levels in blood serum. Effect of ACTH, adrenaline, noradrenaline, hydrocortisone, parathormone, insulin, and glucagon | Q79451275 | ||
| A multi-analytical platform approach to the metabonomic analysis of plasma from normal and Zucker (fa/fa) obese rats | Q80037913 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | metabolomics | Q12149006 |
| obesity | Q12174 | ||
| physiological phenomenon | Q66615932 | ||
| body size | Q66711810 | ||
| P304 | page(s) | 805683 | |
| P577 | publication date | 2012-01-01 | |
| 2012-05-16 | |||
| P1433 | published in | Journal of Biomedicine and Biotechnology | Q15752146 |
| P1476 | title | Investigating potential mechanisms of obesity by metabolomics | |
| P478 | volume | 2012 |
| Q28083355 | A Metabolomic Approach to Understanding the Metabolic Link between Obesity and Diabetes |
| Q53367555 | Alterations of plasma metabolite profiles related to adipose tissue distribution and cardiometabolic risk. |
| Q36423444 | An Investigation into the Antiobesity Effects of Morinda citrifolia L. Leaf Extract in High Fat Diet Induced Obese Rats Using a (1)H NMR Metabolomics Approach |
| Q37166645 | Analysis of Therapeutic Effect of Ilex hainanensis Merr. Extract on Nonalcoholic Fatty Liver Disease through Urine Metabolite Profiling by Ultraperformance Liquid Chromatography/Quadrupole Time of Flight Mass Spectrometry |
| Q54112785 | Anthocyanins Function as Anti-Inflammatory Agents in a Drosophila Model for Adipose Tissue Macrophage Infiltration. |
| Q41146613 | Antiobesity Effects of Anthocyanins in Preclinical and Clinical Studies. |
| Q92735607 | Are we close to defining a metabolomic signature of human obesity? A systematic review of metabolomics studies |
| Q35009033 | Association between plasma nonesterified fatty acids species and adipose tissue fatty acid composition |
| Q37061182 | Associations of anthropometric markers with serum metabolites using a targeted metabolomics approach: results of the EPIC-potsdam study |
| Q58705829 | Characterization of different fat depots in NAFLD using inflammation-associated proteome, lipidome and metabolome |
| Q39995908 | Clinical phenotype clustering in cardiovascular risk patients for the identification of responsive metabotypes after red wine polyphenol intake. |
| Q90523544 | Detection of Early Disease Risk Factors Associated with Metabolic Syndrome: A New Era with the NMR Metabolomics Assessment |
| Q34555259 | Diet-induced hyperinsulinemia differentially affects glucose and protein metabolism: a high-throughput metabolomic approach in rats |
| Q58762949 | Dietary Probiotic Effect of WFLU12 on Low-Molecular-Weight Metabolites and Growth of Olive Flounder () |
| Q64935591 | Dietary Supplementation of Vine Tea Ameliorates Glucose and Lipid Metabolic Disorder via Akt Signaling Pathway in Diabetic Rats. |
| Q34662057 | Distinct signatures of host-microbial meta-metabolome and gut microbiome in two C57BL/6 strains under high-fat diet |
| Q58722698 | Evaluation of Metal Oxide Surface Catalysts for the Electrochemical Activation of Amino Acids |
| Q28534040 | Gender-specific metabolomic profiling of obesity in leptin-deficient ob/ob mice by 1H NMR spectroscopy |
| Q33740729 | Genomic and metabolomic profile associated to microalbuminuria. |
| Q28087145 | Gut Microbiome and Obesity: A Plausible Explanation for Obesity |
| Q57998393 | Impact of maternal obesity on the metabolic profiles of pregnant women and their offspring at birth |
| Q37156548 | Integrative analysis of metabolome and gut microbiota in diet-induced hyperlipidemic rats treated with berberine compounds |
| Q91714048 | Intra-Abdominal Fat Adipocyte Hypertrophy through a Progressive Alteration of Lipolysis and Lipogenesis in Metabolic Syndrome Rats |
| Q47673849 | Maternal obesity and increased neonatal adiposity correspond with altered infant mesenchymal stem cell metabolism |
| Q64248797 | Metabolite Markers for Characterizing Sasang Constitution Type through GC-MS and H NMR-Based Metabolomics Study |
| Q90093949 | Metabolomic Pathways Predicting Labor Dystocia by Maternal Body Mass Index |
| Q92754815 | Metabolomics for Investigating Physiological and Pathophysiological Processes |
| Q47190113 | Metabolomics identifies changes in fatty acid and amino acid profiles in serum of overweight older adults following a weight loss intervention |
| Q59622191 | Metabolomics of diet-related diseases using mass spectrometry |
| Q33766558 | Modulation of the activities of catalase, cu-zn, mn superoxide dismutase, and glutathione peroxidase in adipocyte from ovariectomised female rats with metabolic syndrome |
| Q26752387 | Molecular Mechanisms of the Anti-Obesity and Anti-Diabetic Properties of Flavonoids |
| Q37088255 | Obesity and Asthma: Microbiome-Metabolome Interactions |
| Q35926923 | Obesity, Asthma, and the Microbiome |
| Q37025089 | Obesity-related metabolite profiles of black women spanning the epidemiologic transition |
| Q27001191 | Review: toxicometabolomics |
| Q42706747 | Role of the Gastrointestinal Tract Microbiome in the Pathophysiology of Diabetes Mellitus |
| Q98177969 | Targeted Metabolomics for Plasma Amino Acids and Carnitines in Patients with Metabolic Syndrome Using HPLC-MS/MS |
| Q38702324 | The urine metabolome differs between lean and overweight Labrador Retriever dogs during a feed-challenge |
| Q37717478 | Translational medicine as a new clinical tool and application which improves metabolic diseases: perspectives from 2012 Sino-American symposium on clinical and translational medicine |
| Q55386905 | Visceral abdominal fat measured by computer tomography as a prognostic factor for gynecological malignancies? |
Search more.